Risk Factors for Adverse Outcomes in a Fontan Population
Pediatric Cardiology · 2026
DOI: 10.1007/s00246-025-03902-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pediatric Cardiology, 2026. Verfasst von Giancarlo Licitra und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Emory University School of Medicine, Atlanta, GA, USA. giancarlo.licitra@emory.edu. Hauptthemen laut MEDLINE: Fontan Procedure, Postoperative Complications, Heart Defects, Congenital. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: Centers for Disease Control and Prevention Cooperative Agreement.
Abstract (Originalsprache)
Improved survival following Fontan surgery is tempered by late Fontan failure. Heterogeneous multi-organ complications contribute to eventual Fontan failure varying over time. The prevalence of Fontan-related complications and their association with adverse outcomes were evaluated. A Fontan cohort of 668 pediatric (n = 490) and adult (n = 178) patients from two healthcare systems were linked to 2010-2019 healthcare encounters and death certificates. Bivariate analyses examined covariates by the primary composite outcome of heart transplant, hepatocellular carcinoma (HCC) or death. Multivariate logistic regression explored associations of risk factors with the primary composite outcome and a secondary outcome of hospitalization. Kaplan-Meier curves compared freedom from the primary composite outcome stratified by number of concurrent risk factors at initial encounter. Of 668 Fontan patients, 12.3% developed the primary composite outcome (21.3% adults, 9.0% children). Clinical risk factors increased with age and time, and were significantly associated with HCC, a component of the primary outcome. Patients with 3 + risk factors had significantly worse survival (log-rank p < 0.01). Heart failure (HF) was the strongest independent predictor of outcomes (aOR 5.90, p < 0.01). Dysrhythmia, cyanosis, and HF were associated with more hospitalizations. The primary composite outcome was 4-fold higher with 3 + risk factors (aOR 3.71, 95% CI 2.26-6.16), significant in children (aOR 3.01, 95% CI 1.17-7.0), and adults (aOR 2.58, 95% CI 1.04-7.48). Complications increase as Fontan patients age and are associated with transplant, HCC, death, and hospitalizations in a pediatric and adult cohort. Early identification and intervention for Fontan-related complications may improve late outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Internal Medicine, Emory University School of Medicine, Atlanta, GA, USA. giancarlo.licitra@emory.edu.
- Department of Epidemiology, Emory University Rollins School of Public Health, Atlanta, GA, USA.
- Department of Cardiology, Emory University School of Medicine, Atlanta, GA, USA.
- Department of Biomedical Informatics, School of Medicine, Emory University, Atlanta, GA, USA.
Förderung
- Centers for Disease Control and Prevention Cooperative Agreement
Zitieren
APA
Licitra, G., Ivey, L. C., Raskind-Hood, C. L., Rodriguez, F. H., Guo, Y., Sarker, A., & Book, W. M. (2026). Risk Factors for Adverse Outcomes in a Fontan Population. Pediatric Cardiology. https://doi.org/10.1007/s00246-025-03902-9
Vancouver
Licitra G, Ivey LC, Raskind-Hood CL, Rodriguez FH, Guo Y, Sarker A, et al. Risk Factors for Adverse Outcomes in a Fontan Population. Pediatric Cardiology. 2026. doi:10.1007/s00246-025-03902-9
BibTeX
@article{Licitra2026,
author = {Licitra, Giancarlo and Ivey, Lindsey C and Raskind-Hood, Cheryl L and Rodriguez, Fred H and Guo, Yuting and Sarker, Abeed and Book, Wendy M},
title = {Risk Factors for Adverse Outcomes in a Fontan Population},
journal = {Pediatric Cardiology},
year = {2026},
doi = {10.1007/s00246-025-03902-9}
}
EUVIMED